These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 26239492

  • 1. Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement.
    Karaca B, Ünlü E, Köse G, Gönen E, Çakcı A.
    J Child Neurol; 2016 Mar; 31(3):357-63. PubMed ID: 26239492
    [Abstract] [Full Text] [Related]

  • 2. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ.
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [Abstract] [Full Text] [Related]

  • 3. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 Apr; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 4. Tendon transfer surgery in upper-extremity cerebral palsy is more effective than botulinum toxin injections or regular, ongoing therapy.
    Van Heest AE, Bagley A, Molitor F, James MA.
    J Bone Joint Surg Am; 2015 Apr 01; 97(7):529-36. PubMed ID: 25834076
    [Abstract] [Full Text] [Related]

  • 5. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O, Basaran A, Ayoglu H.
    J Child Neurol; 2011 Apr 01; 26(4):482-7. PubMed ID: 21270468
    [Abstract] [Full Text] [Related]

  • 6. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
    Speth L, Janssen-Potten Y, Leffers P, Rameckers E, Defesche A, Winkens B, Becher J, Smeets R, Vles JS.
    Eur J Paediatr Neurol; 2015 May 01; 19(3):337-48. PubMed ID: 25661064
    [Abstract] [Full Text] [Related]

  • 7. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
    Rameckers EA, Duysens J, Speth LA, Vles HJ, Smits-Engelsman BC.
    J Rehabil Med; 2010 Apr 01; 42(4):332-8. PubMed ID: 20461335
    [Abstract] [Full Text] [Related]

  • 8. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
    Keren-Capelovitch T, Jarus T, Fattal-Valevski A.
    J Child Neurol; 2010 Jun 01; 25(6):694-700. PubMed ID: 20508235
    [Abstract] [Full Text] [Related]

  • 9. Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy.
    Hoare B.
    J Child Neurol; 2014 Aug 01; 29(8):1066-76. PubMed ID: 24820338
    [Abstract] [Full Text] [Related]

  • 10. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
    Hurvitz EA, Conti GE, Brown SH.
    Arch Phys Med Rehabil; 2003 Mar 01; 84(3):444-54. PubMed ID: 12638115
    [Abstract] [Full Text] [Related]

  • 11. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial.
    Wallen MA, O'flaherty SJ, Waugh MC.
    Arch Phys Med Rehabil; 2004 Feb 01; 85(2):192-200. PubMed ID: 14966702
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy.
    Speth LA, Leffers P, Janssen-Potten YJ, Vles JS.
    Dev Med Child Neurol; 2005 Jul 01; 47(7):468-73. PubMed ID: 15991867
    [Abstract] [Full Text] [Related]

  • 13. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.
    Hoare B, Imms C, Villanueva E, Rawicki HB, Matyas T, Carey L.
    Dev Med Child Neurol; 2013 Mar 01; 55(3):238-47. PubMed ID: 23236956
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 Mar 01; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
    Delgado MR, Tilton A, Carranza-Del Río J, Dursun N, Bonikowski M, Aydin R, Maciag-Tymecka I, Oleszek J, Dabrowski E, Grandoulier AS, Picaut P, Dysport in PUL study group.
    Dev Med Child Neurol; 2021 May 01; 63(5):592-600. PubMed ID: 33206382
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
    Kanellopoulos AD, Mavrogenis AF, Mitsiokapa EA, Panagopoulos D, Skouteli H, Vrettos SG, Tzanos G, Papagelopoulos PJ.
    Eur J Phys Rehabil Med; 2009 Dec 01; 45(4):501-6. PubMed ID: 20032908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH, Miller F, Walt SE, Waugh MC, Stott NS.
    Eur J Neurol; 2008 Nov 01; 15(11):1191-8. PubMed ID: 18727674
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.